German S3-guidelines on the treatment of psoriasis vulgaris (short version)

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of Dermatological Research 2012-03, Vol.304 (2), p.87-113
Hauptverfasser:	Nast, A., Boehncke, W. H., Mrowietz, U., Ockenfels, H. M., Philipp, S., Reich, K., Rosenbach, T., Sammain, A., Schlaeger, M., Sebastian, M., Sterry, W., Streit, V., Augustin, M., Erdmann, R., Klaus, J., Koza, J., Müller, S., Orzechowski, H. D., Rosumeck, S., Schmid-Ott, G., Weberschock, T., Rzany, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Clinical Protocols Dermatology Diagnosis, Differential Drug interaction Drug Therapy Evidence-Based Medicine Expert Testimony Germany Guideline Humans Inflammatory diseases Medicine Medicine & Public Health Patient Compliance Patient Satisfaction Psoriasis - diagnosis Psoriasis - epidemiology Psoriasis - physiopathology Psoriasis - therapy psoriasis vulgaris PUVA Therapy Quality of Life Skin - pathology Skin diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!